Skip to main content

Want a detailed portfolio tracker?

Bicycle Therapeutics (BCYC) P/E (2019 - 2026)

Bicycle Therapeutics (BCYC) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Bicycle Therapeutics (BCYC) P/E is -1.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Bicycle Therapeutics (BCYC)

YearP/EChange
2026-1.32-41.14%
2025-2.24-60.00%
2024-5.60+5.64%
2023-5.30-57.40%
2022-12.44-62.60%
2021-33.27+238.33%
2020-9.83-1.81%
2019-10.01N/A

Comparison Bicycle Therapeutics (BCYC) P/E with competitors

Bicycle Therapeutics (BCYC) P/E is -1.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.00-100.33%
ENLVEnlivex Ltd0.07-105.67%
FGENFibroGen Inc0.24-118.21%
CHRSCoherus Biosciences Inc0.85-164.37%
FBIOFortress Biotech Inc0.95-171.99%
ORMPOramed Pharmaceuticals Inc1.50-214.02%
AGENAgenus Inc3.01-328.30%
INVAInnoviva Inc3.15-339.25%
VXRTVaxart Inc3.55-369.27%
CRMDCorMedix Inc3.63-375.24%
CVACCureVac N.V.4.45-437.23%
GLPGGalapagos NV4.86-468.58%
SRPTSarepta Therapeutics Inc4.88-470.34%
ABEOAbeona Therapeutics Inc5.39-508.67%
ABUSArbutus Biopharma Corp5.60-524.46%
ZVRAZevra Therapeutics Inc5.89-546.58%
SPROSpero Therapeutics Inc6.23-572.46%
CGENCompugen Ltd6.31-578.95%
RIGLRigel Pharmaceuticals6.87-621.29%
SLXNSilexion Therapeutics Corp7.30-653.45%
OMEROmeros Corporation9.26-802.33%
AUPHAurinia Pharmaceuticals Inc9.58-827.08%
PLXProtalix BioTherapeutics Inc10.89-926.15%
ACADAcadia Pharmaceuticals Inc11.73-989.68%
TBPHTheravance Biopharma Inc12.26-1030.16%
ADMAAdma Biologics Inc12.42-1041.99%
HRMYHarmony Biosciences Holdings Inc13.82-1148.35%
SABSSAB Biotherapeutics Inc14.14-1172.32%
NAGENiagen Bioscience Inc14.82-1224.05%
INCYIncyte Corp15.82-1300.24%
REGNRegeneron Pharmaceuticals Inc15.86-1302.83%
PBYIPuma Biotechnology Inc17.32-1413.50%
CPRXCatalyst Pharmaceuticals Inc17.44-1422.88%
EXELExelixis Inc17.54-1430.37%
TGTXTG Therapeutics Inc18.97-1538.69%
MDXGMimedx Group Inc20.55-1659.04%
XOMAXOMA Royalty Corp22.87-1835.23%
ARGXArgen X SE24.30-1943.20%
CTMXCytomX Therapeutics Inc24.82-1982.89%
XOMAOXOMA Royalty Corp25.34-2022.61%
HALOHalozyme Therapeutics Inc25.62-2043.77%
XOMAPXOMA Royalty Corp25.67-2047.29%
VRTXVertex Pharmaceuticals Inc27.99-2223.63%
RPRXRoyalty Pharma plc - Class A28.69-2276.19%
SLNOSoleno Therapeutics Inc29.02-2301.05%
ASNDAscendis Pharma A/S30.09-2382.24%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2975.94%
APLSApellis Pharmaceuticals Inc39.02-3060.08%
BMRNBiomarin Pharmaceutical Inc42.21-3302.12%
KRYSKrystal Biotech Inc45.34-3539.68%
ONCBeiGene Ltd69.54-5375.22%
PHARPharming Group N.V.75.03-5791.31%
TECHBio-Techne Corp101.96-7834.39%
VCELVericel Corp109.92-8438.45%
ALNYAlnylam Pharmaceuticals Inc117.96-9048.63%
GMABGenmab140.29-10742.22%
TLXTelix Pharmaceuticals Ltd162.15-12400.64%
CORTCorcept Therapeutics Inc212.86-16247.01%